LON:GENF Genflow Biosciences (GENF) Share Price, News & Analysis GBX 2.10 +0.05 (+2.44%) As of 11:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and Trends About Genflow Biosciences Stock (LON:GENF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Genflow Biosciences alerts:Sign Up Key Stats Today's Range 2▼ 2.1050-Day Range 1.63▼ 2.2552-Week Range 0.76▼ 3.12Volume944,166 shsAverage Volume2.04 million shsMarket Capitalization£11.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Read More Receive GENF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENF Stock News HeadlinesSIRT6 gene therapy shows promise in aged dogs - ICYMIJune 27, 2026 | uk.finance.yahoo.comGenflow Biosciences PLC Announces Participation at BIO International Convention 2026June 22, 2026 | finance.yahoo.com#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"The federal government is throwing its full support behind a new class of AI technology, in what's being called the biggest push since the Apollo moon landing. This AI reportedly works 10,000 times faster than human PhDs and could eventually be worth 500 times more than ChatGPT. Elon Musk has called the underlying tech the most disruptive force in history.September 2 at 1:00 AM | Stansberry Research (Ad)Genflow CEO on showcasing dog longevity gene therapy results at Toronto summitJune 22, 2026 | finance.yahoo.comGenflow Biosciences PLC - Company to present at Animal Longevity Summit 2026June 17, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Notice of AGMJune 5, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Exercise of Warrants and Issue of EquityMay 8, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Final ResultsMay 1, 2026 | finance.yahoo.comSee More Headlines GENF Stock Analysis - Frequently Asked Questions How have GENF shares performed this year? Genflow Biosciences' stock was trading at GBX 1.85 at the beginning of the year. Since then, GENF stock has increased by 13.8% and is now trading at GBX 2.10. How were Genflow Biosciences' earnings last quarter? Genflow Biosciences plc (LON:GENF) posted its quarterly earnings results on Thursday, April, 30th. The company reported ($0.33) earnings per share for the quarter. Genflow Biosciences had a negative net margin of 170.64% and a positive trailing twelve-month return on equity of 332.06%. How do I buy shares of Genflow Biosciences? Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genflow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL). Company Calendar Last Earnings4/30/2026Today9/02/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:GENF CIKN/A Webgenflowbio.com Phone44 32 4774 95881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.76 million Net Margins-170.64% Pretax MarginN/A Return on Equity332.06% Return on Assets-58.66% Debt Debt-to-Equity RatioN/A Current Ratio0.45 Quick Ratio20.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.70 per share Price / Cash Flow3.00 Book ValueGBX 0.25 per share Price / Book8.46Miscellaneous Outstanding Shares566,410,000Free FloatN/AMarket Cap£11.89 million OptionableNot Optionable Beta2.27 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (LON:GENF) was last updated on 9/2/2026 by MarketBeat.com Staff. From Our PartnersGold Explorer Sits Between Barrick’s Nevada GiantsBarrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...Wall Street Logic | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | Sponsored#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"The federal government is throwing its full support behind a new class of AI technology, in what's being calle...Stansberry Research | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredJon Najarian's #1 Energy Trade for 2026Elon Musk just built the largest private power network in American history. Hall of Fame Trader Jon Najarian s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
